Vitalhub Board Re-elected by Shareholders as Digital Health Stock Hits 52-Week Low
27.06.2026 - 05:35:23 | boerse-global.de
A broad majority of brokerages still rate Vitalhub Corp. as a buy despite the digital health company’s shares plunging to their lowest point in a year. Six of seven surveyed houses recommend purchasing, one advises a strong buy, and the consensus price target of C$13.14 is nearly double the stock’s current level. Yet on June 25 the Toronto-listed shares (TSE:VHI) closed at C$6.73 after touching a 52-week trough of C$6.62, with 227,868 shares changing hands. At the peak of the past twelve months the stock traded at C$14.64.
The price slide unfolded as Vitalhub’s annual general meeting confirmed a new board. Shareholders voted Allan Bret, Andrew Shen and Tony Shen onto the company’s control panel. The leadership refresh comes during a turbulent market phase for the firm, whose market capitalisation currently stands at C$445.98 million. Earnings per share over the most recent quarter came in at C$0.04 on revenue of C$31.91 million, yielding a price-to-earnings ratio of 58.75.
Insider trading in the weeks around the meeting tells a mixed story. Director Anthony Pius Shen bought 7,000 shares on March 30 at C$7.11. By contrast, director Steve Garrington sold 10,000 shares on June 5 at C$7.17. Analysts have also revised their expectations downward in recent months. Raymond James trimmed its target to C$11 on March 24, and the National Bank of Canada’s financial arm followed with the same figure on May 27. ATB Cormark had adjusted its target to C$15 back on March 10.
Elsewhere in the sector, Quantum Critical Metals Corp. appointed Tracy Hughes to its board of directors. At MindMaze, shareholders voted on June 25 to re-elect Brad Hollinger and CEO Zach Henderson.
